-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
-
AIPLA CLE Webinar: Post-Grant Strategies for Correcting and Challenging Patent Claims
March 4, 2020 12:30 PM to 2:00 PM | 1.5 CLE Credits
This webinar will provide a summary of post-grant procedures and describe when, why, and how each procedure is useful (or not) to patent owners and third-party challengers.
News
-
Cleveland Clinic Heart Disease Patent Invalid
April 4, 2019
The US Court of Appeals for the Federal Circuit on April 1, 2019, held the Cleveland Clinic Foundation’s heart disease detection patent invalid because the claims of the patent were directed to a natural law and recited no other inventive concept. -
Kroma EU Has No Standing to Sue Kardashian Sisters
April 3, 2019
The Eleventh Circuit on April 1, 2019, held that Kroma EU, a European cosmetics company, lacked standing to sue the Kardashian sisters for trademark infringement in the US. -
Federal Circuit Reverses IBM Patent Invalidation
April 2, 2019
The Court of Appeals for the Federal Circuit on April 1, 2019, held that the Patent Trial and Appeal Board (PTAB) must reconsider its decision to invalidate IBM’s U.S. Patent No. 7,631,346; the patent is related to a system for reducing authentication burdens by allowing a user to sign-in only once while accessing multiple applications. -
Brexit and the European Patent System
April 1, 2019
The UK is due to leave the European Union – an economic and political partnership of 28 countries – ending 46 years of British membership. But the exact timing remains unclear. -
5th Circuit Declines to Disgorge Profits in False Advertising Suit
April 1, 2019
The United States Court of Appeals for the Fifth Circuit on March 26, 2019, affirmed a district court ruling which declined to disgorge Becton Dickinson & Co.’s (BD) profits despite the fact the syringe maker was found liable by a jury on multiple Lanham Act violations.